Canada needs a life sciences industrial strategy, a strengthened clinical trials system and new health infrastructure

Mark Lowey
September 23, 2026

Canada risks losing critical economic growth and innovation potential without implementing a coherent national life sciences strategy, HealthCareCAN says in a pre-budget submission. The organization urges the federal government to develop a national strategy, strengthen the country's clinical trials system and modernize aging health infrastructure to secure the country's position as a global leader in biomedical research and commercialization.

... Please become a Member or login to read the rest of this article ...


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events











Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.